GDF - Medical Technology Development
Abstract
Guidance for Development of the Force - Medical Technology Development provides funds for promising candidate solutions that are selected for initial safety and effectiveness testing in animal studies and/or small-scale human clinical trials regulated by the US Food and Drug Administration prior to licensing for human use. Medical technology development is managed by six Joint Program Committees (JPCs): 1- Medical simulation and information sciences (JPC-1) research aims to coordinate health information technology, simulation, and training research across the Medical Health System. Technology development efforts are directed toward the medical simulation task. 2- Military infectious diseases (JPC-2) research is developing protection and treatment products for military relevant infectious diseases. Technology development efforts are directed against tasks in bacterial diseases, diagnostics development, and viral diseases. 3- Military operational medicine (JPC-5) research goals are to develop and validate medical countermeasures against operational stressors, prevent physical and psychological injuries during training and operations, and to maximize health, performance and fitness of Service members. Technology development efforts are directed against tasks in musculoskeletal injury; brain health and performance risk; behavioral health, wellness and resilience; warfighter physical performance; nutrition and weight balance; psychiatry and clinical psychology disorders; neurosensory performance, injury and protection; blunt, blast and accelerative injury; environmental toxicant exposure; and aircrew health and performance. 4- Combat casualty care (JPC-6) research is optimizing survival and recovery in injured Service members across the spectrum of care from point of injury through enroute and facilities care. Technology development efforts are directed against tasks in hemorrhage, shock, and coagulopathy of trauma; TBI neurotrauma and brain dysfunction; treatments for extremity trauma, tissue injury, craniomaxillofacial injury, lung injury, and burns; pre-hospital tactical combat casualty care; enroute care; and military medical photonics. 5- Radiation health effects (JPC-7) research focuses on core capabilities to support technology development of radiation medical countermeasures development, to include demonstration of improved survivability after treatment with selected therapeutic candidates for acute radiation exposure, and identifying radioprotectants (preventative treatment) for further development. 6- Clinical and rehabilitative medicine (JPC-8) is developing knowledge and materiel products to reconstruct, rehabilitate, and provide care for injured Service members. Technology development efforts are directed against tasks in neuromusculoskeletal rehabilitation, pain management, regenerative medicine, and sensory systems. As research efforts mature, the most promising will transition to advanced concept development funding, PE 0604110. For knowledge products, successful findings will transition into clinical practice guidelines.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2017
- Source ID
- 373A_0603115DHA_2_0130_PB_2017
Related Documents
- Root: Medical Technology Development
- Child Accomplishment: GDF – Medical Technology Development